As of Friday close, agilon health inc.’s (NYSE:AGL) stock was up $0.04, moving up 0.22 percent to $18.43. The average number of shares traded per day over the past five days has been 2,429,060 shares. 1 time new highs have been achieved over the past 5 days, with a -$0.32 fall in that time frame. In the last twenty days, the average volume was 2,081,780, while in the previous 50 days, it was 2,312,470.
Since last month, AGL stock rose 7.40%. Shares of the company fell to $16.42 on 08/24/23, the lowest level in the past month. A 52-week high of $29.44 was reached on 03/27/23 after having rallying from a 52-week low of $15.00. Since the beginning of this year, AGL’s stock price has risen by 14.19% or $2.29, and marked a new high 25 times. However, the stock has declined by -37.40% since its 52-week high.
AGL stock investors should be aware that agilon health inc. (AGL) stock had its last reported insider trading activity 10 days ago on Sep 13. Shaker Benjamin, the Chief Markets Officer of the company, disposed of 18,750 shares for $18.00 on Sep 13. It resulted in a $337,455 divestment by the insider. Shaker Benjamin sold 18,750 shares at an average price of $18.05 on Sep 12. The insider now owns 79,543 shares following the transaction. On Sep 11, Chief Accounting Officer Gertsch Timothy sold 26,250 shares at $18.61 apiece. The transaction was valued at $488,616.
Valuation Metrics
The stock’s beta is 0.95. Besides these, the trailing price-to-sales (P/S) ratio of 1.95, the price-to-book (PB) ratio of 8.61.
Financial Health
In the three months ended June 29, agilon health inc.’s quick ratio stood at 1.50, while its current ratio was 1.50, showing that the company is able to pay off its debt. According to company report, the long-term debt-to-equity ratio for the quarter ending June 29 was 0.04, and the total debt-to-equity ratio was 0.05. On the profitability front, the trailing twelve-month gross margin is 12.00% percent. In the year ended June 29, EBITDA margin amounted to -3.85%, whereas operating margins totaled -3.30%. Based on annual data, AGL earned $112.29 million in gross profit and brought in $2.71 billion in revenue.
A company’s management is another factor that investors consider when determining the profitability of an investment. In the past year, return on investment (ROI) was -11.80%. Return on equity (ROE) for the past 12 months was -8.60%.
In agilon health inc.’s quarter-end financial report for June 29, it reported total debt of $36.02 million. According to the earnings report, the company had a higher net income in the recent quarter than it did in the previous quarter. AGL’s revenue rose 41.68% to $1.14 billion during the quarter, while net income inched up to $1.15 billion. While analysts expected agilon health inc. to report -$0.02 quarterly earnings, the actual figure was -$0.04 per share. During the quarter, the company generated -$24.31 million in EBITDA. The liabilities of agilon health inc. were 1.47 billion at the end of its most recent quarter ended June 29, and its total debt was $50.97 million. The value of shareholders’ equity is $405.48 million.
Technical Picture
This quick technical analysis looks at agilon health inc.’s (AGL) price momentum. With a historical volatility rate of 35.11%, the RSI 9-day stood at 55.18% on 22 September.
With respect to its five-day moving average, the current agilon health inc. price is down by -1.71% percent or -$0.32. At present, AGL shares trade +10.23% above its 20-day simple moving average and -24.16% percent below its 100-day simple moving average. However, the stock is currently trading approximately +11.70% above its SMA50 and +4.01% above its SMA200.
Stochastic coefficient K was 60.41% and Stochastic coefficient D was 58.53%, while ATR was 0.69. Given the Stochastic reading of 67.96% for the 14-day period, the RSI (14) reading has been calculated as 53.28%. As of today, the MACD Oscillator reading stands at 0.06, while the 14-day reading stands at 0.08.
Analyst Ratings
Evercore ISI launched its rating on agilon health inc. (NYSE: AGL) to an In-line in a note to investors on June 13, 2023. agilon health inc. (AGL) has been rated Buy by analysts. According to 0 brokerage firms, AGL is a sell, and 2 firms recommend it is a Hold. There are 0 analysts who say the stock is underweight. A total of 0 analysts rate agilon health inc. stock as buy, with 13 recommending it as overweight.
